Seth Lederman
2012
In 2012, Seth Lederman earned a total compensation of $1.1M as Chief Executive Officer at Tonix Pharmaceuticals Holding.
Compensation breakdown
| Option Awards | $822,715 |
|---|---|
| Other | $279,750 |
| Total | $1,102,465 |
Lederman received $822.7K in option awards, accounting for 75% of the total pay in 2012.
Lederman also received $279.8K in other compensation.
Rankings
In 2012, Seth Lederman's compensation ranked 5,732nd out of 11,487 executives tracked by ExecPay. In other words, Lederman earned more than 50.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,732 out of 11,487 | 50th |
Division Manufacturing | 2,037 out of 4,253 | 52nd |
Major group Chemicals And Allied Products | 498 out of 1,198 | 58th |
Industry group Drugs | 337 out of 920 | 63rd |
Industry Pharmaceutical Preparations | 264 out of 700 | 62nd |
Source: SEC filing on May 2, 2014.
Lederman's colleagues
We found two more compensation records of executives who worked with Seth Lederman at Tonix Pharmaceuticals Holding in 2012.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019